Navigation Links
ADVENTRX Pharmaceuticals Provides Update on ANX-514
Date:2/15/2011

events or results may differ materially from those expressed or implied by the forward-looking statements in this press release due to a number of risks and uncertainties, including, without limitation: the potential for the FDA to require significant further nonclinical studies and/or clinical testing of ANX-514, including more than one clinical trial, which generally are more costly and lengthy than bioequivalence trials; the risk that additional nonclinical and/or clinical activities required by the FDA prior to the filing or the approval of a New Drug Application (NDA) for ANX-514 may result in ADVENTRX's determination that the commercial potential of ANX-514 does not justify the required investment and ADVENTRX's discontinuation of the program; the risk that, if ADVENTRX determines to continue development of ANX-514, ADVENTRX may need to raise additional capital to fund the additional development activities required by the FDA and that the necessity of such activities may negatively impact ADVENTRX's ability to raise additional capital for development of and/or partner ANX-514; difficulties or delays in manufacturing ANX-514 for additional clinical or bioequivalence studies; difficulties or delays in obtaining regulatory approval for ANX-514, even if ADVENTRX conducts additional nonclinical and/or clinical activities required by the FDA, including the potential for automatic injunctions regarding FDA approval of ANX-514 and other challenges by patent holders during the Section 505(b)(2) process; difficulties or delays in manufacturing and marketing ANX-514, including validating commercial manufacturing processes and manufacturers, as well as suppliers; ADVENTRX's reliance on the performance of third parties to assist in the conduct of its nonclinical, clinical and bioequivalence studies, regulatory submissions, CMC activities, commercial launch activities and other important aspects of the Exelbine and ANX-514 development programs, and that such third parties
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
2. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
5. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
6. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
7. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
8. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
9. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
10. ADVENTRX Reports Third Quarter Financial Results
11. ADVENTRX to Present at the Wall Street Analyst Forum 21st Annual Institutional Investor Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Research and Development Trend Forecast of Pharmaceutical ... offering. Research and Development Trend Forecast ... , 2014-2018 mainly analyzes China,s ... status, supply & demand, competition landscape, and business performance ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2District Court Decision Received In Remodulin Patent Case 2
... Health Corp. (Nasdaq: WBMD ) today announced that executives of ... Small and Mid Cap Conference on Friday, November 20, 2009 at ... public are invited to listen to a live audio broadcast of ... at www.wbmd.com (in the Investor Relations section). ...
... , NEW HAVEN, Conn., Nov. 17 HistoRx ... image analysis platform based on tissue-based quantitative immunofluorescence, was noted ... Task Force Report on hormone receptor testing in ... being developed for the measurement of ER and PgR in ...
Cached Medicine Technology:AQUA(R) Technology Recognized as 'Promising New Strategy' for Hormone Receptor Testing in Breast Cancer by NCCN Task Force 2
(Date:8/29/2014)... 2014 Top10inaction, a professional product review ... in the online service industry for the month of ... Webex, GotoMeeting and Infinite. , With over thousands of ... determine which provider is ideally a good fit for ... for compelling consumer goods and services agencies to assist ...
(Date:8/29/2014)... -- Selling cigarettes in plain packages doesn,t increase the ... sales in small stores, according to new research from ... industry when it tried to prevent Australia from becoming ... packaging for tobacco products in 2012. Similar legislation is ... Researchers surveyed nearly 2,000 adult smokers in Australia ...
(Date:8/29/2014)... 29, 2014 The 8th Annual Paint Columbus ... for a Cause, Pink Pooch Contest, Light of Life Ceremony, ... Knots" Pink Bow Campaign – all in support of cancer ... twist this year…. Paint Columbus Pink Foam and Obstacle Challenge ... Hills, 727 54th Street, Columbus, Georgia 31904. It will be ...
(Date:8/29/2014)... Older adults who stay active by volunteering are getting ... they are receiving a health boost! ... Institute at Baycrest Health Sciences and published online this ... to take a broad-brush look at all the available ... volunteering for older adults. , Lead investigator Dr. Nicole ...
(Date:8/29/2014)... 2014 After having a double mastectomy ... to have breast reconstruction. She found that the look ... decided that there needed to be a solution. , ... woman or man who needs or wants breast improvements. ... confidence and peace of mind. Producible in design variations, ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2
... Trustees Names Long-Time Twin Cities Health Care ... ... G. Mishek, a Minnesota native,with extensive executive-level experience in health care, ... organization that,helps people reclaim their lives from addiction. The appointment was ...
... carbon dioxide levels add to discomfort of ragweed allergies ... suffering for people with ragweed allergies to the list ... suggests. , Recent research indicates that increasing global ... seasons and more concentrated pollen counts, says the American ...
... age at menopause as well as a woman,s breastfeeding ... of breast cancer. That was the conclusion of a ... of CANCER, a peer-reviewed journal of the ... are distinct and separate hormonal risk factors associated with ...
... announces iCan Insurance, LLC ("iCan Insurance", "iCan") is now offering ... ... Boca Raton, FL (PRWEB) August 24, ... ("iCan Insurance", "iCan") is now offering major medical health plans ...
... 32,000 Sq. Ft. Facility Helps Tackle Health Care Crisis by Providing ... ... of Los Angeles County, LOS ANGELES, Aug. 22 ... the grand opening of the,Family Health and Wellness Center located in ...
... concludes that nearly 13 percent of America,s aged citizens suffer ... they have suffered from verbal mistreatment, 3.5 percent suffer financial ... reported in the latest issue of The Journal ... , The research was conducted by a team headed by ...
Cached Medicine News:Health News:Mark G. Mishek Is New President and CEO of Hazelden 2Health News:Climate Change Linked to Longer Pollen Seasons 2Health News:Breastfeeding, other factors may affect risk of breast cancer type 2Health News:iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products 2Health News:AltaMed Opens First-of-its-Kind Health Care Center in the Nation 2Health News:AltaMed Opens First-of-its-Kind Health Care Center in the Nation 3Health News:AltaMed Opens First-of-its-Kind Health Care Center in the Nation 4Health News:Research finds America's elderly suffering abuse 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: